OCT drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (7)
Papers in which this entity is mentioned.
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. (2025)
- Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. (2024)
- Spatially resolved whole transcriptome profiling in human and mouse tissue using Digital Spatial Profiling. (2022)
- Joint single-cell measurements of nuclear proteins and RNA in vivo. (2021)
- Comparative RNA-seq analysis aids in diagnosis of a rare pediatric tumor. (2019)
- Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| oct | drug | 23 | 28 |
| optimal cutting temperature compound | drug | 1 | 1 |
| optimal cutting temperature | drug | — | — |